230 related articles for article (PubMed ID: 28919188)
1. [Contribution of multimodal imaging in the various stages of Stargardt disease].
El Matri L; Falfoul Y; Kortli M; Hassairi A; Charfi H; Turki A; Kort F; Chebil A
J Fr Ophtalmol; 2017 Oct; 40(8):666-675. PubMed ID: 28919188
[TBL] [Abstract][Full Text] [Related]
2. The dark atrophy with indocyanine green angiography in Stargardt disease.
Giani A; Pellegrini M; Carini E; Peroglio Deiro A; Bottoni F; Staurenghi G
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3999-4004. PubMed ID: 22589445
[TBL] [Abstract][Full Text] [Related]
3. Dark Atrophy: An Optical Coherence Tomography Angiography Study.
Pellegrini M; Acquistapace A; Oldani M; Cereda MG; Giani A; Cozzi M; Staurenghi G
Ophthalmology; 2016 Sep; 123(9):1879-86. PubMed ID: 27448830
[TBL] [Abstract][Full Text] [Related]
4. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
[TBL] [Abstract][Full Text] [Related]
5. Early-onset stargardt disease: phenotypic and genotypic characteristics.
Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
[TBL] [Abstract][Full Text] [Related]
6. Multimodal imaging in multiple evanescent white dot syndrome and new insights in pathogenesis.
Monferrer Adsuara C; Remolí Sargues L; Montero Hernández J; Hernández Garfella ML; Hernández Bel L; Castro Navarro V; Cervera Taulet E
J Fr Ophtalmol; 2021 Dec; 44(10):1536-1544. PubMed ID: 34728098
[TBL] [Abstract][Full Text] [Related]
7. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
Sisk RA; Leng T
Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
[TBL] [Abstract][Full Text] [Related]
8. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of autofluorescence and OCT angiography in Stargardt disease.
Guduru A; Lupidi M; Gupta A; Jalali S; Chhablani J
Br J Ophthalmol; 2018 Sep; 102(9):1204-1207. PubMed ID: 29074493
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characteristics of childhood-onset Stargardt disease.
Fujinami K; Zernant J; Chana RK; Wright GA; Tsunoda K; Ozawa Y; Tsubota K; Robson AG; Holder GE; Allikmets R; Michaelides M; Moore AT
Ophthalmology; 2015 Feb; 122(2):326-34. PubMed ID: 25312043
[TBL] [Abstract][Full Text] [Related]
11. Prognostication in Stargardt Disease Using Fundus Autofluorescence: Improving Patient Care.
Daich Varela M; Laich Y; Hashem SA; Mahroo OA; Webster AR; Michaelides M
Ophthalmology; 2023 Nov; 130(11):1182-1190. PubMed ID: 37331482
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
[TBL] [Abstract][Full Text] [Related]
13. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
[TBL] [Abstract][Full Text] [Related]
14. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
Cai CX; Light JG; Handa JT
Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757
[TBL] [Abstract][Full Text] [Related]
16. En face OCT in Stargardt disease.
Sodi A; Mucciolo DP; Cipollini F; Murro V; Caporossi O; Virgili G; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1669-79. PubMed ID: 26743751
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic characteristics of late-onset Stargardt's disease.
Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
[TBL] [Abstract][Full Text] [Related]
18. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.
Gomes NL; Greenstein VC; Carlson JN; Tsang SH; Smith RT; Carr RE; Hood DC; Chang S
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3953-9. PubMed ID: 19324865
[TBL] [Abstract][Full Text] [Related]
19. Early Patterns of Macular Degeneration in ABCA4-Associated Retinopathy.
Khan KN; Kasilian M; Mahroo OAR; Tanna P; Kalitzeos A; Robson AG; Tsunoda K; Iwata T; Moore AT; Fujinami K; Michaelides M
Ophthalmology; 2018 May; 125(5):735-746. PubMed ID: 29310964
[TBL] [Abstract][Full Text] [Related]
20. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]